Try it
Pharmacology · Lipid-lowering drugs
Sample itemA patient started on nicotinic acid for dyslipidaemia complains of intense facial flushing and warmth. Which drug taken beforehand reduces this adverse effect, and why?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. Aspirin, by inhibiting prostaglandin D2 synthesis
Niacin-induced flushing is mediated by prostaglandin D2 released from skin cells through a niacin receptor. Aspirin taken before the dose blunts the flush by cyclooxygenase inhibition. Flushing also lessens with continued use.
Option by option
A. Aspirin, by inhibiting prostaglandin D2 synthesis (correct)
Correct. Cyclooxygenase inhibition reduces the prostaglandin mediator of flushing.
B. Propranolol, by blocking beta receptors
Beta-blockers do not address the prostaglandin-mediated vasodilatation.
C. Atropine, by blocking muscarinic receptors
Atropine would add anticholinergic effects and does not block the flush.
D. Cetirizine, by blocking H1 receptors fully
The flush is not mainly histamine-mediated, so H1 blockade gives little benefit.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?